Current and future treatments for hepatocellular carcinoma

Area of Science:

• Hepatology and Oncology
• Cancer Treatment and Management

Background:

• Hepatocellular carcinoma (HCC) presents significant management challenges with no single curative treatment.
• Treatment decisions require balancing clinical guidelines, patient concerns, and quality of life.

Purpose of the Study:

• To systematically review current hepatocellular carcinoma treatment modalities.
• To detail clinical data, risks, rewards, and outcomes for each approach.
• To explore molecular pathways for potential drug development in HCC.

Main Methods:

• Comprehensive review of surgical (resection, transplantation, ablation) and radiation (radiotherapy, microspheres, proton/heavy ion) modalities.
• Analysis of Sorafenib, a biologic agent, and relevant clinical trials.
• Detailed examination of molecular pathways involved in HCC initiation and progression.

Main Results:

• Current HCC treatments include diverse surgical, radiation, and emerging biologic options.
• Understanding molecular pathways offers potential for novel therapeutic strategies.
• Each treatment modality presents unique risks, benefits, and patient outcomes.

Conclusions:

• Informed decision-making for HCC requires a thorough understanding of all available treatment options.
• Future HCC management may involve targeted therapies based on molecular pathway analysis.
• This review provides a comprehensive resource for clinicians and patients navigating HCC treatment complexities.